Product Overview
Clinical StudyPal’s DCT service automates the patient enrollment process, on-boarding patients more efficiently—securely and ethically.
Delve Health offers a comprehensive suite of decentralized clinical trial (DCT) services designed to make trials more patient-centric, efficient, and accessible. By leveraging cutting-edge technology, our decentralized solutions break down traditional barriers, empower patients, and deliver high-quality, reliable data for sponsors. This transformation offers numerous benefits, including:
- Enhanced Patient Engagement: Personalized support and automated digital interactions improve patient retention and compliance, ensuring more reliable study outcomes.
- Faster Trial Implementation: Rapid deployment of wearable devices and digital solutions reduces setup time, helping sponsors start trials quickly and achieve results faster.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Patient Engagement & Retention
Engaging patients throughout the trial is crucial for success. Delve Health offers:
- Automated Digital Interactions: SMS, mobile app, and email reminders that keep patients informed and motivated.
- Concierge Services: Personalized support to guide patients every step of the way, ensuring they feel valued and comfortable participating in the study.
- Gamification: Interactive elements that encourage participation, leading to increased retention and higher quality data.
Wearable Integration & Data Operationalization
Wearable devices are key to collecting continuous, real-world patient data. We provide:
- Fast Wearable Deployment: Reduce wearable integration time from 6 months to just 4 weeks through our partnerships with leading technology providers.
- End-to-End Data Management: Automate data collection, cleaning, normalization, and integration, making wearable data immediately actionable to support study endpoints effectively.
About the company
We are a digital healthcare and clinical trials platform and services company that partners our technology solutions with companies and organizations that sponsor Phase I – IV studies. We welcome the opportunity to discuss how we can implement solutions that will automate your workflows and increase efficacy and patient retention.
